UBS’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$20K Hold
1,500
﹤0.01% 8031
2014
Q2
$24K Hold
1,500
﹤0.01% 7861
2014
Q1
$27K Sell
1,500
-2,900
-66% -$50.2K ﹤0.01% 7699
2013
Q4
$68K Sell
4,400
-300
-6% -$4.42K ﹤0.01% 6558
2013
Q3
$70K Buy
4,700
+2,500
+114% +$37.7K ﹤0.01% 6427
2013
Q2
$28K Buy
+2,200
New +$29.5K ﹤0.01% 7476

Other funds holding MDRX

UBS's MDRX Position: Q3 2014 in Review

UBS increased its Veradigm Inc. Common Stock (MDRX) stake by 31% in Q3 2014, buying an estimated $4.75M and bringing the position to 1,311,935 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #1041.

UBS first reported a position in MDRX in Q2 2013 and has held it in 6 quarters since. 225 funds tracked by Wall St. Rank hold MDRX as of Q3 2014.

  • UBS held 1,311,935 shares of Veradigm Inc. Common Stock worth $17.6M as of Q3 2014.
  • UBS bought 313,606 Veradigm Inc. Common Stock shares in Q3 2014, an estimated $4.75M.
  • Veradigm Inc. Common Stock made up 0.01% of UBS's portfolio in Q3 2014, its #1041 holding.
  • UBS first reported a position in Veradigm Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
  • 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.